EN ISO 10993-7:2026
Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2026)
Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2026)
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 135
- Дата публикации:
- 20 мая 2026 г.
- Издание:
- CEN EN 10993 edition 2 version 1
- ICS:
- 11.100.20
This document specifies allowable limits (AL) for residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) in EO-sterilized medical devices, procedures for the measurement of EO and ECH, and methods for determining conformity so that devices can be released. Additional background, including guidance and a flowchart showing how this document is applied, are also included in Annexes A, B, C, D, E, F, G, H, I, J and K. EO-sterilized devices or components that have neither direct nor indirect body or user contact (e.g. in vitro diagnostic devices) are out of scope of this document. This document does not apply to devices that have been demonstrated to not absorb or retain EO or its degradation product ECH, such as medical devices made exclusively of metal alloys and glass, see Clause C.5[228]. NOTE This document does not specify limits for ethylene glycol (EG). No device limits are specified for EG because the risk assessment in Annex F indicates that calculated allowable levels are higher than those likely to occur in a medical device.
Abstract
Overview
EN ISO 10993-7:2026 is an internationally recognized standard developed by CEN, defining requirements for the biological evaluation of medical devices specifically with regards to residuals resulting from ethylene oxide (EO) sterilization. The standard specifies allowable limits (AL) for EO and ethylene chlorohydrin (ECH) remaining on medical devices after sterilization, outlines precise measurement procedures, and sets forth methods for conformity assessment before product release. Its primary aim is to minimize patient risk by controlling potential toxicological effects from EO and ECH residues, thus supporting device safety and regulatory compliance.
This document includes detailed background information, comprehensive guidance, and illustrative flowcharts in its annexes to facilitate correct application by manufacturers and processors of EO-sterilized medical devices.
Key Topics
- Allowable Residual Limits: The standard establishes clear thresholds for EO and ECH residuals on sterilized devices, categorized by anticipated patient contact duration.
- Device Categorization: Devices are categorized based on contact time (limited, prolonged, or long-term), influencing the allowable limits for EO and ECH.
- Measurement Procedures: Defined procedures and validation requirements for measuring EO and ECH are provided, ensuring accurate assessment.
- Conformity Assessment: Methods for determining device compliance with allowable limits are detailed, supporting systematic batch release.
- Risk Assessment: The standard encourages risk-based approaches for determining appropriate residual limits considering the device’s intended use and patient population.
- Exclusions: The document does not apply to devices without direct or indirect patient contact, or to those made exclusively from non-absorbent materials like metal or glass. It does not set limits for ethylene glycol (EG) due to minimal associated risk.
- Guidance and Tools: Numerous annexes offer additional background, rationales for limits, example calculations, and product release methods.
Applications
EN ISO 10993-7:2026 is essential for manufacturers, quality management teams, and regulatory departments involved in:
- Medical Device Manufacturing: Guiding the safe use of EO sterilization, ensuring that residuals are consistently below prescribed allowable limits.
- Quality Control and Assurance: Providing standardized procedures for sampling, extraction, and analytical measurement of EO and ECH residuals.
- Regulatory Compliance: Facilitating compliance with European and international medical device regulations that reference this standard, such as the EU Medical Device Regulation (MDR, 2017/745).
- Product Development: Supporting risk management and biocompatibility assessments during device design and validation stages, especially when EO sterilization is selected.
- Routine Process Validation: Enabling consistent evaluation and requalification of sterilization processes to ensure ongoing safety and effectiveness.
The standard's structured approach helps organizations minimize toxicological health risks for both patients and end-users, optimize sterilization processes, and demonstrate compliance during audits or regulatory review.
Related Standards
- EN ISO 10993-1: Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- EN ISO 10993-17: Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances
- EN ISO 10993-23: Biological evaluation of medical devices - Tests for irritation
- EN ISO 11135: Sterilization of health care products – Ethylene oxide – Requirements for development, validation and routine control of a sterilization process
These standards collectively enable robust biological evaluation, risk assessment, and quality assurance for EO-sterilized medical devices.
Keywords: EN ISO 10993-7:2026, ethylene oxide residuals, ECH residuals, biological evaluation, EO sterilization, medical device standard, allowable limits, conformity assessment, medical device regulation, CEN, ISO standards, medical device safety, biocompatibility, residual testing.
Технические детали
- Технический комитет
- CEN/TC 206 - Biocompatibility of medical and dental materials and devices
- SKU
- EN ISO 10993-7:2026
Похожие стандарты
Стандарты, упомянутые в описании
ISO 10993-7:2026
ДействующийBiological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals
Overview ISO 10993-7:2026 is an international standard developed by ISO for the biological evaluation of medical devices, focusing specifically on Part 7: Ethylene oxide sterilization residuals. This…
ISO 10993-12:2012
ОтменёнBiological evaluation of medical devices — Part 12: Sample preparation and reference materials
ISO 10993-17:2023
ДействующийBiological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constitue…
Overview ISO 10993-17:2023 - Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - defines a standardized process for performing toxicolog…
ISO 10993-23:2021
ДействующийBiological evaluation of medical devices — Part 23: Tests for irritation
Overview - ISO 10993-23:2021 (Tests for irritation) ISO 10993-23:2021 is part of the ISO 10993 series on the biological evaluation of medical devices. It specifies procedures to assess the potential…
ISO 11135:2014
ДействующийSterilization of health-care products — Ethylene oxide — Requirements for the development, validation and rou…
Overview ISO 11135:2014 - Sterilization of health‑care products - Ethylene oxide specifies the requirements for the development, validation and routine control of an ethylene oxide (EO) sterilization…